News Release

December 29, 2019

EVMS Scientist And CHKD Pediatrician Pursue Drug For Potential “blue baby” Treatment

“blue baby” Treatment

THE VIRGINIAN-PILOT | DEC 29, 2019

https://www.pilotonline.com/news/health/vp-nw-fzx19-realta-life-sciences-20191229-ufzi7vhgu5f3nppfatihjcgq3a-story.html

MORE NEWS & INDUSTRY UPDATES

Feb 16, 2021

ReAlta Life Sciences Doses First Subject In Phase 1 Healthy Volunteers Study...

Norfolk, VA, February 16, 2021 – ReAlta Life Sciences, Inc. (“ReAlta”), a company addressing life-threatening diseases through harnessing the power...

Read More
Dec 03, 2020

ReAlta Life Sciences Announces EMA Orphan Drug Designation for RLS-0071 For The...

Norfolk, VA, December 3, 2020 — ReAlta Life Sciences, Inc., today announced that the European Medicines Agency (EMA) has granted Orphan...

Read More
Nov 19, 2020

ReAlta Life Sciences Featured In Norfolk Innovation Corridor, Launch Of New Technology...

Norfolk, VA, November 19, 2020 — Norfolk, Virginia, known globally for its expertise in resilience and strong entrepreneurship ecosystem, is...

Read More